ANALYSIS OF RECOMBINANT ACTIVATED FACTOR VII USAGE FOR BLEEDING CONTROL IN CASES OF HEMORRHAGIC SHOCK
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, B. Y. | - |
dc.contributor.author | Park, J. H. | - |
dc.contributor.author | Huh, J. W. | - |
dc.contributor.author | Lim, C. -M. | - |
dc.contributor.author | Koh, Y. | - |
dc.contributor.author | Hong, S. -B. | - |
dc.date.accessioned | 2024-06-17T06:30:54Z | - |
dc.date.available | 2024-06-17T06:30:54Z | - |
dc.date.issued | 2011-09 | - |
dc.identifier.issn | 0342-4642 | - |
dc.identifier.issn | 1432-1238 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/74280 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | SPRINGER | - |
dc.title | ANALYSIS OF RECOMBINANT ACTIVATED FACTOR VII USAGE FOR BLEEDING CONTROL IN CASES OF HEMORRHAGIC SHOCK | - |
dc.type | Article | - |
dc.identifier.bibliographicCitation | INTENSIVE CARE MEDICINE, v.37, no.S1, pp S49 - S49 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000209082800176 | - |
dc.citation.endPage | S49 | - |
dc.citation.number | S1 | - |
dc.citation.startPage | S49 | - |
dc.citation.title | INTENSIVE CARE MEDICINE | - |
dc.citation.volume | 37 | - |
dc.type.docType | Meeting Abstract | - |
dc.publisher.location | 미국 | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Critical Care Medicine | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.